Biotech Startups

Sapala Organics is a contract research and manufacturing organization (CRO/CDMO) specializing in nucleic acid chemistry, oligonucleotide synthesis, and medicinal chemistry for the pharmaceutical industry. Now a subsidiary of Cohance Lifesciences, the company provides drug discovery and development services focused on genetic therapies and complex small molecule synthesis.

1 investor

Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.

1 investor

The company develops cancer immunotherapy treatments. Based on the team composition and mission statement, it operates in the biotech and healthcare sectors.

1 investor

Satellos is a biotechnology company developing oral small molecule therapies that restore the body's natural muscle regeneration process by targeting muscle stem cell asymmetric division. Its lead candidate, forazapadin, targets degenerative muscle diseases, beginning with Duchenne muscular dystrophy and facioscapulohumeral muscular dystrophy (FSHD).

1 investor

Sayre Therapeutics is a pharmaceutical company operating across India, South Asia, and Southeast Asia that distributes differentiated global drugs and treatments for rare and orphan diseases to emerging markets. The company brings novel medical solutions to patients and clinicians in oncology and rare disease care.

1 investor

SB TEMPUS supports personalized medicine for cancer treatment by integrating medical data and AI. The company offers genetic testing, medical data utilization, and AI applications serving healthcare institutions, pharmaceutical companies, and biotech ventures.

1 investor

SC Therapeutics is a clinical-stage biopharmaceutical company developing aerosol therapeutics made of ions naturally present in human airways to restore mucosal hydration and reduce upper-airway and systemic inflammation. Its treatments target respiratory conditions such as chronic cough and cardiovascular conditions such as hypertension.

1 investor

SCA Pharma supplies critical medications to pharmacies. It positions itself as a pharmaceutical products provider.

1 investor

SCAI Therapeutics develops pharmaceutical and cosmetic products based on its proprietary platform technology, MOASIS. The company is a startup based in South Korea.

1 investor

Scale Biosciences develops patented single-cell analysis technology that enables researchers to conduct massively parallelized sequencing at reduced cost. The company serves biomedical research labs seeking to study complex cell biology at scale.

1 investor

Scale Medicine is an AI-native pharmaceutical company that applies artificial intelligence to improve the success rates of its clinical trials.

1 investor

Scancell is a UK clinical-stage biotechnology company developing off-the-shelf active immunotherapies for cancer using its Immunobody and Moditope platforms, with a lead melanoma product (iSCIB1+) and a solid-tumour candidate (Modi-1). Through its subsidiary Glymab Therapeutics, it is also developing GlyMab and AvidiMab antibody technologies targeting tumour-specific glycans for solid cancers.

1 investor

ScandiBio Therapeutics is a biotechnology company developing therapeutics based on research from leading Swedish and UK academic institutions. The company was founded by researchers from KTH Royal Institute of Technology, Karolinska Institutet, Sahlgrenska Academy, and King's College London.

1 investor

Scarlet Therapeutics develops a platform that produces lab-grown, universal red blood cell-based therapeutics (tRBCs) engineered to carry high levels of therapeutic proteins for treating a range of diseases. It initially targets rare metabolic diseases such as hyperammonemia and hyperoxaluria, with potential applications in other metabolic diseases, cancer, and autoimmune conditions.

1 investor

SCD Probiotics develops a fermentation-based biological platform that grows multiple microbial strains together into consortia to produce probiotics and microbial biochemicals. Its products serve applications ranging from gut and home health to industrial uses such as leather processing, offering bio-based, non-toxic alternatives to petroleum-based chemicals.

1 investor

Clinical-stage biopharmaceutical company focused on discovery and development of innovative medicines for serious diseases by targeting the Transforming Growth Factor Beta pathway.

1 investor

Schrödinger develops a physics-based computational platform for discovering and optimizing molecules, used to accelerate drug discovery and materials design. The company also operates a therapeutics group that pursues drug development on validated targets and offers educational resources for the field.

1 investor

Dr. Willmar Schwabe is a family-owned pharmaceutical company that researches, develops, and manufactures herbal medicines (phytopharmaceuticals) derived from plants, controlling the full production process from planting to packaging. Its products are sold through pharmacies and manufactured in Germany.

1 investor

Scieline provides a data management and R&D workflow platform for research teams in biotech, chemistry, and food & beverage sectors to streamline experiment design, execution, and data capture. The platform replaces paper-based and spreadsheet-driven research with automated, governed data management and process-driven tools.

1 investor

Science Care operates a non-transplant tissue banking program that partners with medical researchers and educators, enabling donor contributions for medical research, education, and product development. Founded in 2000, the organization manages donation programs while prioritizing donor dignity, ethical practices, and industry standards.

1 investor

Science Park provides project expertise in scientific-technical, technological, and marketing domains, and assists with preparing projects for financing and seed-stage syndicated investments.

1 investor

Scientifica designs and supplies electrophysiology equipment, including systems and components for patch clamp, in vivo electrophysiology, multiphoton imaging, and optogenetics, along with technical training and support. It serves neuroscience, cardiology, cancer, and other scientific research communities worldwide.

1 investor

SCIEX develops mass spectrometry and capillary electrophoresis instruments, along with software and integrated workflows, for the precision detection and quantitation of molecules. Its products serve research scientists and clinical laboratories, including in vitro diagnostic applications.

1 investor

SciLeads provides a database and platform for identifying, engaging, and qualifying research scientists as sales prospects, serving B2B scientific companies globally with lead generation and market research capabilities.

1 investor